Research, discovery, and translation to practice are at the core of the mission for the George Washington University School of Medicine and Health Sciences. By accelerating research excellence, enhancing innovation, and advancing translation, our goal is to make discoveries and improve clinical care.
The scientific workforce, composed of highly educated researchers and scientists-in training, clinician investigators, as well as skilled technical support staff, project managers, and core team members, together contribute to research discovery. Training the next generation of biomedical scientists is a key goal.
Funding and support, obtained from federal and non-federal grants and contracts, private industry investment, and philanthropy, is essential to sustain our research programs. SMHS provides funding opportunities and strategies to gain support.
Moncef Slaoui, PhD, MBA, chief adviser for the COVID-19 vaccine development initiative Operation Warp Speed, visited GW on Oct. 21 to raise awareness for the national vaccine development efforts, encourage greater participation in the clinical trials and recognize GW for exceeding its enrollment goals for its vaccine trial.
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.